Ryali Sriram Insider Trades

Insider Trading History

Track insider trading activity for Ryali Sriram. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Caribou Biosciences
Caribou Biosciences CRBU
Chief Financial Officer
Holding Value $511k 247,500 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$545k 302,500 shares
$1.80
$2.06
Caribou Biosciences
Caribou Biosciences CRBU
Chief Financial Officer
Holding Value $35.8k 17,360 shares
Last Trade
Jan 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.7k 17,360 shares
$1.42
$2.06
Caribou Biosciences
Caribou Biosciences CRBU
Chief Financial Officer
Holding Value $620k 300,000 shares
Last Trade
Jan 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$492k 300,000 shares
$1.64
$2.06
Codexis
Codexis CDXS
Chief Financial Officer
Holding Value $880k 314,125 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$958k 314,125 shares
$3.05
$2.80
Codexis
Codexis CDXS
Chief Financial Officer
Holding Value $346k 123,441 shares
Last Trade
Sep 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.8k 11,650 shares
$1.70
$2.80
Codexis
Codexis CDXS
Chief Financial Officer
Holding Value $1.04M 372,637 shares
Last Trade
Feb 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 372,637 shares
$5.86
$2.80
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $71.7k 41,566 shares
Last Trade
Mar 14, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$358k 2,266 shares
$158.10
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Director, Chief Financial Officer
Holding Value $247k 143,000 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.4M 310,000 shares
$153.00
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $51.8k 30,000 shares
Last Trade
Jul 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.34M 30,000 shares
$244.50
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $150k 87,000 shares
Last Trade
May 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2M 87,000 shares
$254.70
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $168k 97,500 shares
Last Trade
Mar 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.1M 113,750 shares
$299.70
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $112k 65,000 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9M 65,000 shares
$168.00
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $2.81k 1,628 shares
Last Trade
Mar 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 229 shares
$258.00
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $2.41k 1,399 shares
Last Trade
Sep 05, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.3k 149 shares
$330.60
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $2.16k 1,250 shares
Last Trade
Apr 22, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$411k 1,250 shares
$329.10
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Chief Financial Officer
Holding Value $155k 90,000 shares
Last Trade
Jan 03, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.2M 90,000 shares
$313.80
$1.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up